Table 2.
COVID-19 Antibody | Time of Specimen Collection (Days) | |||
---|---|---|---|---|
After the First Dose | 60 Days after Second Dose | 150 Days after Second Dose | 270 Days after Second Dose | |
Anti-Spike antibody | 77.2 (19.4–329.4) | 512 (114.5–9212) | 149 (51.6–2283) | 2079 (433.9–8644) |
Neutralising antibody (%) | 22.1 (8.5–54.2) | 52.3 (7.7–92.7) | 41.1 (3.8–86.4) | 58.6 (17.6–85.1) |
Anti-spike antibody titre is expressed as U/mL and neutralising antibody is expressed in percentage. The anti-spike antibody titre value ≥ 0.80 U/mL is considered positive. The specimens with calculated neutralisation ≥ 20% are considered positive for neutralising antibody. Data are expressed as median (inter quartile range).